Key result
The PROMED randomized pilot trial was designed to evaluate a culturally-tailored Mediterranean-like diet in 50 Puerto Rican adults to improve a composite cardiometabolic score.
Why the study?
Studies evaluating the cardiometabolic benefits of the Mediterranean diet among non-Mediterranean racial and ethnic minorities remain limited.
Does a culturally-tailored Mediterranean-like diet improve a composite cardiometabolic score in adults with cardiometabolic risk factors in Puerto Rico?
RCT (n=50)
parallel two-arm
No
Does a culturally-tailored Mediterranean-like diet improve a composite cardiometabolic score in adults with cardiometabolic risk factors in Puerto Rico?
The PROMED trial is designed to evaluate the efficacy of a culturally-tailored Mediterranean-like diet on cardiometabolic health in Puerto Rican adults.
Addresses MedDiet evidence gap for Puerto Ricans; extends research to underrepresented minorities.
Background: Adhering to a Mediterranean Diet (MedDiet) is associated with a healthier cardiometabolic profile. However, there are limited studies on the MedDiet benefits for non-Mediterranean racial/ethnic minorities, for whom this diet may be unfamiliar and inaccessible and who have a high risk of chronic diseases. Objectives: To describe the study design of a pilot trial testing the efficacy of a MedDiet-like tailored to adults in Puerto Rico (PR). Methods: The Puerto Rican Optimized Mediterranean-like Diet (PROMED) was a single-site 4-mo parallel two-arm randomized pilot trial among a projected 50 free-living adults (25-65 y) living in PR with at least two cardiometabolic risk factors (clinicaltrials.gov registration #NCT03975556). The intervention group received 1 individual nutritional counseling session on a portion-control culturally-tailored MedDiet. Daily text messages reinforced the counseling content for 2 mo, and we supplied legumes and vegetable oils. Participants in the control group received cooking utensils and one standard portion-control nutritional counseling session that was reinforced with daily texts for 2 mo. Text messages for each group were repeated for two more months. Outcome measures were assessed at baseline, 2 and 4 m. The primary outcome was a composite cardiometabolic improvement score; secondary outcomes included individual cardiometabolic factors; dietary intake, behaviors, and satisfaction; psychosocial factors; and the gut microbiome. Results: PROMED was designed to be culturally appropriate, acceptable, accessible, and feasible for adults in PR. Strengths of the study include applying deep-structure cultural components, easing structural barriers, and representing a real-life setting. Limitations include difficulty with blinding and with monitoring adherence, and reduced timing and sample size. The COVID-19 pandemic influenced implementation, warranting replication. Conclusions: If PROMED is proven efficacious in improving cardiometabolic health and diet quality, the findings would strengthen the evidence on the healthfulness of a culturally-appropriate MedDiet and support its wider implementation in clinical and population-wide disease-prevention programs.
No takes yet. Share an insight, caveat, or question.
Mattei et al. (2022) conducted an RCT in cardiometabolic risk factors (n=50). Puerto Rican Optimized Mediterranean-like Diet (PROMED) vs. Standard portion-control nutritional counseling was evaluated on composite cardiometabolic improvement score. The PROMED randomized pilot trial was designed to evaluate a culturally-tailored Mediterranean-like diet in 50 Puerto Rican adults to improve a composite cardiometabolic score.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: